Details for New Drug Application (NDA): 040306
✉ Email this page to a colleague
NDA 040306 describes METADATE ER, which is a drug marketed by Lannett Co Inc and is included in two NDAs. Additional details are available on the METADATE ER profile page.
The generic ingredient in METADATE ER is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
The generic ingredient in METADATE ER is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for 040306
| Tradename: | METADATE ER |
| Applicant: | Lannett Co Inc |
| Ingredient: | methylphenidate hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
| Approval Date: | Oct 20, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
